Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysis
Armen Aprikian, Andrew Chilelli, Thomas W. McLean, Anchen F. Nasr et autres
ca, gb, nl, jp, us (code pays fourni par la source)